MUST Clinical Trials Centre Joins NMPA GBA Center for Drug Evaluation and Inspection Delegation Visit to Hong Kong
Clinical Trials Centre of Macau University of Science and Technology (MUST-CTC), was honored to join the meeting with the delegation from the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) Center for Drug Evaluation and Inspection of National Medical Products Administration (NMPA) in Hong Kong on June 26, 2025. This significant event focused on advancing clinical research development within the GBA.
Dr. Valencia Chang, Executive Director of MUST-CTC, engaged in an in-depth exchanges with the delegation. Together with the representatives from ClinCluster® platform, including HKU Clinical Trials Centre and Gleneagles Clinical Trials Centre, she affirmed the achievements of the platform through sharing the journey of establishment of MUST-CTC. Discussion emphasized how ClinCluster® integrates resources from clinical trials institutions across the GBA to facilitate communication, collaboration, and resource sharing, while promoting exchange of talents, technology, and data in the region.
The ClinCluster® platform received positive comments from the delegation of NMPA GBA Center. MUST-CTC will continue deepening strategic alliances with all ClinCluster® partners, infusing new dynamics to accelerate the initiation of clinical research and jointly pioneer impactful clinical research.
